[ Price : $8.95]
FDA posts a draft guidance entitled Considerations for Including Tissue Biopsies in Clinical Trials.[ Price : $8.95]
FDA releases a draft guidance entitled Considerations for the Use of Artificial Intelligence (AI) to Support Regulatory Decision-M...[ Price : $8.95]
Neumora Therapeutics says its Phase 3 KOASTAL-1 Study of navacaprant for treating major depressive disorder missed its primary end...[ Price : $8.95]
CDER approves 50 novel products in 2024, five less than the 55 products approved in 2023 and well above the 10-year rolling annual...[ Price : $8.95]
FDA approves Galdermas Nemluvio to treat some dermatitis patients aged 12 and older.[ Price : $8.95]
FDA says Alcon recalled one lot of Systane Ultra PF eye drops due to potential fungal contamination.[ Price : $8.95]
FDA approves Array BioPharmas Braftovi to treat some patients with metastatic colorectal cancer with a specific mutation.[ Price : $8.95]
FDA warns Greeces Rontis Hellas about Quality System and Medical Device Reporting violations in its production of a balloon cathet...